Investigation of Uric Acid and Nitric Oxide as Risk Factors for Acute Ischemic Stroke Patients

Objective: Cerebrovascular diseases are diseases with a multifactorial etiology, which is affected by genetic and environmental factors, with incidence rates increasing with age around the world. The primary objective of this study was to investigate uric acid and nitric oxide (NO) as risk factors for ischemic stroke patients and to examine the effects of these factors on a patient's prognosis at an early stage.Materials and Methods: Forty patients who were admitted to the hospital because of ischemic stroke were included in the study.Results: NO levels in the patient group were found to be 34.98 ?mol/L, which was significantly higher than that of the control group (p=0.0043); however, uric acid levels in the patient group were found to be 6.54 mg/dl, which was also significantly higher than the control group (p=0.001). In addition, it was shown that the relationship between the NO and uric acid measurements in the patient group was positively and statistically significant (r=0.397, p<0.05).Conclusion: This study indicates that uric acid and NO play a role in the pathogenesis of ischemic stroke; however, they do not contribute to determining the prognosis. It was demonstrated that uric acid is an independent risk factor, when other risk factors are eliminated. When examining the risk factors for ischemic stroke patients, uric acid should be considered and should be among the treatment options.

Kaynakça

Donnan GA, Fisher M, Macleod M, Davis SM. Stroke. Lancet 2008; 371(9624): 1612-23. [CrossRef]

Bonita R, Beaglehole R, Asplund K. The worldwide problem of stroke. Curr Opin Neurol 1994; 7(1): 5-10. [CrossRef]

Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V. World- wide stroke incidence and early case fatality reported in 56 popula- tion-based studies: a systematic review. Lancet Neurol 2009; 8(4): 355-69. [CrossRef]

Kolomiminsky-Rabas PL, Weber M, Gefeller O, Neundoerfer B, Heu- schmann PU. Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrens, and long-term survial in isch- emic stroke subtypes, a populatıon-based study. Stroke 2001; 32: 2735-40. [CrossRef]

Weaver J, Liu KJ. Does normobaric hyperoxia increase oxidative stress in acute ischemic stroke? A critical review of the literature. Med Gas Res 2015; 25: 5-11. [CrossRef]

Weir CJ, Muir SW, Walters MR, Lees KR. Serum urate as an indepen- dent predictor of poor outcome and future vascular events after acute stroke. Stroke 2003; 34(8): 1951-6. [CrossRef]

So A, Thorens B. Uric acid transport and disease. J Clin Invest 2010; 120(6): 1791-9. [CrossRef]

Bergamini C, Cicoira M, Rossi A, Vassanelli C. Oxidative stress and hyperuricaemia: pathophysiology, clinical relevance, and therapeutic implications in chronic heart failure. Eur J Heart Fail 2009; 11(5): 444-52. [CrossRef]

Wink DA, Mitchell JB. Chemical Biology of nitric oxide: Insights into regulatory, cyotoxic, and cytoprotective mechanism of nitric oxide. Free Radic Biol Med 1998; 25(4-5): 434-56. [CrossRef]

Lowenstein CJ, Dinerman JL, Snyder SH. Nitric oxide: a phyiologic messenger. Ann Intern Med 1994; 120(3): 227-37. [CrossRef]

Diakite B, Hamzi K, Slassi I, El Yahyaoui M, El Alaoui MM, Habbal R, et al. G894T endothelial nitric oxide synthase polymorphism and ischemic stroke in Morocco. Meta Gene 2014; 2: 349-57. [CrossRef]

Culleton BF, Larson MG, Kannel WB, Levy D. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med 1999; 131(1): 7-13. [CrossRef]

Milionis HJ, Kalantzi KJ, Goudevenos JA, Seferiadis K, Mikhailidis DP, Elisaf MS. Serum uric acid levels and risk for acute ischaemic non-embolic stroke in elderly subjects. J Intern Med 2005; 258(5): 435-41. [CrossRef]

Ho WJ, Tsai WP, Yu KH, Tsay PK, Wang CL, Hsu TS, Kuo CT. As- sociation between endothelial dysfunction and hyperuricaemia. Rheu- matology (Oxford) 2010; 49(10): 1929-34. [CrossRef]

Llull L, Amaro S, Chamorro A. Administration of Uric Acid in the Emergency Treatment of Acute Ischemic Stroke. Curr Neurol Neuro- sci Rep 2016; 16(1): 4 [CrossRef]

Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA. Hy- peruricemia and risk of stroke: a systematic review and meta-analysis. Arthritis Rheum 2009; 61(7): 885-92. [CrossRef]

Newman EJ, Rahman FS, Lees KR, Weir CJ, Walters MR. Elevat- ed serum urate concentration independently predicts poor outcome following stroke in patients with diabetes. Diabetes Metab Res Rev 2006; 22(1): 79-82. [CrossRef]

Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA. Hy- peruricemia and risk of stroke: a systematic review and meta-analysis. Arthritis Rheum 2009; 61(7): 885-92. [CrossRef]

Moncado S. The 1991 Ulf von Euler Lecture. The L-arginine: nitric oxide pathway. Acta Physiol Scand 1992; 145(3): 201-27. [CrossRef]

Garber Y, Tanne D, Medalie JH, Goldbourt U. Serum uric acid and long-term mortality from stroke, coronary heart disease and all causes. Eur J Cardiovasc Prev Rehabil 2006; 13(2); 193-8. [CrossRef]

Milionis HJ, Kalantzi KJ, Goudevenos JA, Seferiadis K, Mikhailidis DP, Elisaf MS. Serum uric acid levels and risk for acute ischaemic non-embolik stroke in elderly subjects. J Intern Med 2005; 258(5): 435-41. [CrossRef]

Chen JH, Chuang SY, Chen HJ, Yeh WT, Pan WH. Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study. Arthritis Rheum 2009; 61(2): 225-32. [CrossRef]

Squadrito GL, Cueto R, Splenser AE, Valavanidis A, Zhang H, Uppu RM, et al. Reactionof uric acid with peroxynitrite and implications for the mechanism of neuroprotection by uric acid. Arch Biochem Bio- phys 2000; 376(2): 333-7.[CrossRef]

Kaynak Göster